SIMVASTATIN

Product NDC
68788-8369
11-digit product format
687888369
Labeler code
68788
Product ID
68788-8369_77fef2fe-24ac-4bd3-a789-151641d2561e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
SIMVASTATIN
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Preferred Pharmaceuticals, Inc.
Application
ANDA078103
Marketing category
ANDA
Marketing start
2023-02-01
Substance
SIMVASTATIN
Active strength
10 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

openFDA Listing Details

Product ID
68788-8369_77fef2fe-24ac-4bd3-a789-151641d2561e
Product type
HUMAN PRESCRIPTION DRUG
Finished product
Yes
Brand name base
SIMVASTATIN
Generic name
SIMVASTATIN
Dosage form
TABLET, FILM COATED
Route
ORAL
Marketing start
2023-02-01
Marketing category
ANDA
Application number
ANDA078103
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
Listing expiration
2026-12-31

Related Records

openFDA Active Ingredients

IngredientStrength
SIMVASTATIN10 mg/1

openFDA Harmonized Identifiers

FieldValues
UniiAGG2FN16EV
Rxcui314231
Spl Set Ide73ec981-e477-4412-befd-7b807aceb32e
Manufacturer NamePreferred Pharmaceuticals, Inc.

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
AGG2FN16EVSIMVASTATIN79902-63-9SIMVASTATIN

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
68788-8369-168788836901100 TABLET, FILM COATED in 1 BOTTLE (68788-8369-1) 2023-02-01NoNoCurrent
68788-8369-36878883690330 TABLET, FILM COATED in 1 BOTTLE (68788-8369-3) 2023-02-01NoNoCurrent
68788-8369-66878883690660 TABLET, FILM COATED in 1 BOTTLE (68788-8369-6) 2023-02-01NoNoCurrent
68788-8369-96878883690990 TABLET, FILM COATED in 1 BOTTLE (68788-8369-9) 2023-02-01NoNoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
SIMVASTATINPreferred Pharmaceuticals, Inc.2025-09-23HUMAN PRESCRIPTION DRUG LABEL3